title: Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. 2003.
authors.forename: James
authors.initials: J
authors.lastname: Shepherd
authors.forename: Donald B
authors.initials: DB
authors.lastname: Hunninghake
authors.forename: Philip
authors.initials: P
authors.lastname: Barter
authors.forename: James M
authors.initials: JM
authors.lastname: McKenney
authors.forename: Howard G
authors.initials: HG
authors.lastname: Hutchinson
mesh_terms: D000069059:Atorvastatin; D003327:Coronary Disease / Q000266:history* / Q000517:prevention & control; D005464:Fluorobenzenes / Q000266:history* / Q000627:therapeutic use; D006040:Goals; D006538:Heptanoic Acids / Q000266:history* / Q000627:therapeutic use; D049673:History, 20th Century; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000266:history* / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000266:history* / Q000627:therapeutic use; D008055:Lipids / Q000097:blood / Q000266:history; D017410:Practice Guidelines as Topic; D017035:Pravastatin / Q000266:history* / Q000627:therapeutic use; D011743:Pyrimidines / Q000266:history* / Q000627:therapeutic use; D011758:Pyrroles / Q000266:history* / Q000627:therapeutic use; D012307:Risk Factors; D000068718:Rosuvastatin Calcium; D019821:Simvastatin / Q000266:history* / Q000627:therapeutic use; D013449:Sulfonamides / Q000266:history* / Q000627:therapeutic use
chemical_list: D005464:Fluorobenzenes; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D008055:Lipids; D011743:Pyrimidines; D011758:Pyrroles; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; D000069059:Atorvastatin; D019821:Simvastatin; D017035:Pravastatin